ShanX MedTech (SXM),  Aidian Oy, Biosurfit S.A., Unitron B.V. and Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal get together to advance SXM’s proprietary antimicrobial susceptibility testing (AST) technology through product development to regulatory approval. SXM coordinates and leads the group. The work is being carried out under the awarded HADEA/2025/CPN/0006 call for tender, with the contract signed with the European Health and Digital Executive Agency (HaDEA), in line with the policy priorities set by the European Commission’s Health Emergency Preparedness and Response Authority (DG HERA), and funded under the EU4Health Programme.

ShanX MedTech, Erasmus Medical Center and AMR GLOBAL enter a contractual agreement to clinically validate the novel platform for Urinary Tract Infections with financial support from Health Holland, under grant #LSHM22031.